Real World Study Clinical Trials
0 recruiting
Showing 1–2 of 2 trials
Recruiting
TRIMPACT: Real-World First-Line Atezolizumab Use in Stage IV NSCLC With PD-L1 ≥50%
NSCLC Stage IVPD-L1 Gene MutationAtezolizumab+1 more
Antalya Training and Research Hospital150 enrolled19 locationsNCT07279402
Recruiting
Real World Study of Lolatinib for Advanced ALK+ NSCLC Patients
Real World StudyALK-positive Non-small Cell Lung Cancer
Sichuan Cancer Hospital and Research Institute200 enrolled1 locationNCT06361589